Nickname: Alan

Review: I am disturbed to read these types of articles because it gives false hope when the FDA hasn't even approved it for use in breast cancer patients. The article only points out the good and doesn't talk about the side effects such as increased chance of stroke. Also aromatase inhibitors have already been proven to be superior compared to Tamoxifen with minimal side effects. Journalists need to be more responsible when reporting on these types of "claims".

Date reviewed: Apr 19, 2006 1:39 PM

Nickname: Rick

Review: There are plenty of free reports available from AstraZeneca (the company that invented tamoxifen, aka Nolvadex)). I would recommend going to them and checking it out for yourself. It's www.nolvadex.com and you can order a free prescribing information which has a whole lot of information about studies that have been conducted, etc. I just completed a presentation on it and am very surprised to see all of the information about it.

Date reviewed: Apr 18, 2006 11:50 PM

Nickname: al

Review: The Star trials are "double blind" studies. The test subjects are evaluated against a control group of similar persons (age, sex, medical conditions, etc.) who receive a placebo. The results of those persons who took the drug are compared against the control group. Only those events that have statistically significant differences between groups are presumed to be attributed to the drug. There is no confusion.

Date reviewed: Apr 18, 2006 8:56 PM

Nickname: Dessolena

Review: True, "There is no cure for breast cancer". Doesn't mean that women are not living after diagnosis. They are. However, they would be better served by the facts, not false hope or perpetuation of a culture of fear. If you are a post-menopausal and diagnosed with ER+ breast cancer, your oncologist should already know about raloxifene. Activists do. Of course, it will only help a percentage of postmenopausal women diagnosed with ER+ breast cancer. For others diagnosed, raloxifene is not an option. Women would be best served by: - Knowing if their tumors will respond to targeted treatment - Discovering the cause of breast cancer - then perhaps we can prevent or cure it - Health care industry moving towards preventive support rather vs. reactive medicine. Chemoprevention is expensive. Too many embraced the gold standard of tamoxifen, which can have horrendous effects on quality of life, leading to overtreatment.

Date reviewed: Apr 18, 2006 5:42 PM

Nickname: Maya

Review: Interesting. But do tell me, when I am on Tamoxifen, how to cut the risks of blood clotting and endometrial cancer? Are there some recommended drugs that can be taken along with Tamoxifen to minimize these risks -- at least the risk of blood clotting. Second, is there a clear correlation between tamoxifen and cataracts? After all, cataract occurs in patients of an older age group who also form the bulk of breast cancer patients. Couldn't this coincidence be a source of confusion?

Date reviewed: Apr 18, 2006 7:44 AM

Nickname: drrkptr

Review: Latest and advanced information on osteoporosis and breast cancer needed.

Date reviewed: Apr 18, 2006 6:46 AM